APC anti-mouse Ly-6G Antibody

Product Details

Verified Reactivity

Mouse

Antibody Type

Monoclonal

Host Species

Rat

Immunogen

Ly-6G transfected EL-4J cell line.

Formulation

Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.

Preparation

The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.

Concentration

0.2 mg/ml

Storage & Handling

The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.

Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.06 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser

Red Laser (633 nm)

Application Notes

While 1A8 recognizes only Ly-6G, clone RB6-8C5 recognizes both Ly-6G and Ly-6C. Clone RB6-8C5 binds with high affinity to mouse Ly-6G molecules and to a lower extent to Ly-6C¹⁵. Clone RB6-8C5 impairs the binding of anti-mouse Ly-6G clone 1A8¹⁵. However, clone RB6-8C5 is able to stain in the presence of anti-mouse Ly-6C clone HK1.4¹⁶.

Additional reported applications (for the relevant formats) include: immunohistochemistry⁹ of frozen sections¹⁰ and paraffin-embedded sections¹¹, depletion^{4, 12-14}, and spatial biology (IBEX)^20,21. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for in vivo studies or highly sensitive assays (Cat. No. 127632, 127649, 127650, 127661 and 127662).

Application References

(PubMed link indicates BioLegend citation)

1. Fleming TJ, et al. 1993. J. Immunol. 151:2399. (FC)
2. Daley JM, et al. 2008. J. Leukocyte Biol. 83:1. (FC)
3. Dietlin TA, et al. 2007. J. Leukocyte Biol. 81:1205. (FC)
4. Daley J, et al. 2007. J. Leukocyte Biol. doi:10.1189. (Deplete) PubMed
5. Tadagavadi RK, et al. 2010. J. Immunol. 185:4904. PubMed
6. Sumagin R, et al. 2010. J. Immunol. 185:7057. PubMed
7. Guiducci C, et al. 2010. J. Exp Med. 207:2931. PubMed
8. Fujita M, et al. 2011. Cancer Res. 71:2664. PubMed
9. Van Leeuwen, et al. 2008. Arterioscler. Thromb. Vasc. Biol. 28:84. (IHC)
10. Kowanetz M, et al. 2010. P. Natl. Acad. Sci. USA 107:21248. [supplementary data] (IHC)
11. Esbona K, et al. 2016. Breast Cancer Res. 18:35. (IHC)
12. Wojtasiak M, et al. 2010. J. Gen. Virol. 91:2158. (FC, Deplete)
13. Jaeger BN, et al. 2012. J. Exp. Med. 209:565. (Deplete)
14. Wozniak KL, et al. 2012. BMC Immunol. 13:65 (FC, Deplete)
15. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
16. Ng LG, et al. 2011. J Invest. Dermatol. 131:2058. PubMed
17. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
18. McCartney-Francis, N, et al. 2014. J Leukoc. Biol. 96:917. PubMed
19. Her Z, et al. 2014. EMBO Mol. Med. 7:24. PubMed
20. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
21. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed

Product Citations

1. Xue F, et al. 2020. Int J Biol Sci. 2.105555556. PubMed
2. Patras KA, et al. 2019. J Innate Immun. :1. PubMed
3. Yu‐Han Chang et al. 2017. Immunity. 47(5):943-958 . PubMed
4. Li A, et al. 2020. Oncol Lett. 1.899305556. PubMed
5. Ding Z, et al. 2021. Int J Mol Sci. 22:. PubMed
6. Cornax I, et al. 2021. Microorganisms. 9:00. PubMed
7. Stein K, et al. 2016. J Leukoc Biol. 99: 231 - 239. PubMed
8. Christian D, et al. 2014. Infect Immun . 82:4056. PubMed
9. Sharma A, et al. 2014. J Infect Dis. . PubMed
10. Jones NM, et al. 2019. BMC Cancer. 1.127777778. PubMed
11. Herisson F, et al. 2018. Nat Neurosci. 21:1209. PubMed
12. Li Y, et al. 2021. Basic Res Cardiol. 116:30. PubMed
13. Poli V, et al. 2021. iScience. 24:103256. PubMed
14. Xu ZH, et al. 2021. Mediators Inflamm. 2021:8856326. PubMed
15. Weiss M, et al. 2015. Proc Natl Acad Sci U S A. 112: 11001-11006. PubMed
16. Zhang Z, et al. 2020. J Immunol. 204:3400. PubMed
17. Gonçalves NP, et al. 2017. J Neuroinflammation. 14:115. PubMed
18. Kobayashi Y, et al. 2018. PLoS One. 13:e0195008. PubMed
19. Shu T, et al. 2022. Eur Respir J. Online ahead of print. PubMed
20. Zhang Q, et al. 2021. Theranostics. 11:8301. PubMed
21. Han J, et al. 2022. FEBS J. 289:417. PubMed
22. Shani O, et al. 2020. Cancer Res. 80:5317. PubMed
23. Cheng G, et al. 2021. iScience. 24:102673. PubMed
24. Meng L, et al. 2021. Front Oncol. 11:691705. PubMed
25. Mathur S, et al. 2021. JCI Insight. 6:. PubMed
26. Chen F, et al. 2022. Evid Based Complement Alternat Med. 2022:1240242. PubMed
27. Royzman D, et al. 2022. Front Immunol. 13:1012647. PubMed
28. Patnode M, et al. 2014. J Exp Med. 211:1281. PubMed
29. Liao H, et al. 2015. Rheumatology. 54: 1317 - 1326. PubMed
30. Schiller M, et al. 2021. Immunity. 54(5):1022-1036.e8. PubMed
31. Thompson ER, et al. 2020. Am J Transplant. . PubMed
32. Wang X, et al. 2021. Front Cell Dev Biol. 632805:9. PubMed
33. Uroda T, et al. 2020. Nat Protoc. 15:2107. PubMed
34. Di Gioia M, et al. 2020. Nat Immunol. 21:42. PubMed
35. Khan IM, et al. 2021. Immunohorizons. 5:703. PubMed
36. Bourn JR, et al. 2021. Cancer Lett. 503:75. PubMed
37. Yao ME, et al. 2022. Evid Based Complement Alternat Med. 2022:7784148. PubMed
38. Pawaria S, et al. 2020. Arthritis Rheumatol. 72:359. PubMed
39. Schlegel M, et al. 2018. J Clin Invest. 128:4711. PubMed
40. Lee M, et al. 2014. PLoS One. 9:112666. PubMed
41. Mooney J, et al. 2015. Sci Rep. 5: 14603. PubMed
42. Ma Y, et al. 2016. Cardiovasc Res. 110: 51 - 61. PubMed
43. Karmakar M, et al. 2016. Nat Commun. 7:10555. PubMed
44. Chu C, et al. 2016. Dis Model Mech. 9: 473-481. PubMed
45. Liu M, et al. 2020. Cell Rep. 32:107990. PubMed
46. Koren N, et al. 2021. Cell Host Microbe. 29(2):197-209.e5. PubMed
47. Parlet CP, et al. 2019. Cell Rep. 27:187. PubMed
48. Fujita K, et al. 2019. Proc Natl Acad Sci U S A. 116:14714. PubMed
49. McAlpine CS, et al. 2021. Nature. 595:701. PubMed
50. Goldman E, et al. 2021. Cells. 10:. PubMed
51. Kornstädt L, et al. 2021. Front Immunol. 11:607048. PubMed
52. Pan YC, et al. 2021. Mol Ther Oncolytics. 20:175. PubMed
53. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
54. Fulham MA, et al. 2019. Am J Physiol Cell Physiol. 317:C687. PubMed
55. Michael BD, et al. 2020. Cell Reports. 32(11):108150. PubMed
56. Ulrich-Lewis JT, et al. 2022. Front Immunol. 13:861710. PubMed
57. Horn KJ, et al. 2022. Nat Commun. 13:3321. PubMed
58. Friedman DJ, et al. 2021. Cancer Immunol Res. 9:952. PubMed
59. Formaglio P, et al. 2021. Immunity. 54:2724. PubMed
60. Bao C, et al. 2021. Infect Immun. 89:. PubMed
61. Guo P, et al. 2021. J Immunol. 207:408. PubMed
62. Cui C, et al. 2021. Cell. 184(12):3163-3177.e21. PubMed
63. Okubo K, et al. 2021. Cell Reports. 35(7):109142. PubMed
64. Abdul Pari AA, et al. 2020. Cancer Res. 80:2586. PubMed
65. Körner A, et al. 2019. Nat Commun. 10:633. PubMed
66. Doonan J, et al. 2019. Nat Commun. 10:1554. PubMed
67. Rashidi M, et al. 2019. J Immunol. 203:736. PubMed
68. Wang W, et al. 2020. Immunity. 51(6):1102-1118.e7.. PubMed
69. Gottfried-Blackmore A, et al. 2009. Proc Natl Acad Sci U S A. 106:20918. PubMed
70. Yang J, et al. 2022. Microbiome. 10:149. PubMed
71. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
72. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
73. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
74. Wang D, et al. 2021. Nat Commun. 12:2674. PubMed
75. Zhu H, et al. 2021. Cell Metabolism. :. PubMed
76. Tartey S, et al. 2021. Cancer Research. 81(9):2358-2372. PubMed
77. Zhou Q, et al. 2014. J Immunol. 193:496. PubMed
78. Cheng Y, et al. 2020. PLoS Pathog. 16:e1008569. PubMed
79. Körner A, et al. 2019. Proc Natl Acad Sci U S A. 116:20623. PubMed
80. Kulkarni U, et al. 2019. Mucosal Immunol. 12:545. PubMed
81. Wang SS et al. 2018. Cell chemical biology. 25(12):1519-1532 . PubMed
82. Cho K, et al. 2021. iScience. 24:103117. PubMed
83. Gurusamy M, et al. 2021. Nat Commun. 12:6798. PubMed
84. Shan C, et al. 2021. Front Immunol. 12:766401. PubMed
85. Machácek T, et al. 2022. PLoS Pathog. 18:e1010302. PubMed
86. Xiao Y, et al. 2022. Dis Markers. 2022:1380560. PubMed
87. Bolkhovitina EL, et al. 2022. Int J Mol Sci. 23:. PubMed
88. Monteran L, et al. 2022. Nat Commun. 13:5797. PubMed
89. Price P, et al. 2015. J Immunol. 194:1164. PubMed
90. Albarrán-Juárez J, et al. 2016. Atherosclerosis. 251:445-53. PubMed
91. Guldner IH, et al. 2020. Cell. 183(5):1234-1248.e25. PubMed
92. Fraccarollo D, et al. 2021. eLife. 0.416666666666667. PubMed
93. Li H, et al. 2019. Front Immunol. 2.205555556. PubMed
94. Endoh M, et al. 2020. Cell Reports. 30(6):1823-1834. PubMed
95. Toth K, et al. 2022. PLoS Biol. 20:e3001526. PubMed
96. Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed
97. Zhao D, et al. 2020. Cancer Discov. 10:1374. PubMed
98. Steichen A, et al. 2015. PLoS One. 10:123573. PubMed
99. Cohen M, et al. 2014. EMBO J. 33:2906. PubMed
100. Liu Z, et al. 2020. Cell. 178(6):1509-1525.e19.. PubMed
101. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
102. Denny JE, et al. 2019. Sci Rep. 2.786111111. PubMed
103. Janela B, et al. 2019. Immunity. 50:1069. PubMed
104. Smith CA, et al. 2019. JCI Insight. 4. PubMed
105. Wuggenig P, et al. 2020. Commun Biol. 3:130. PubMed
106. Namiguchi K, et al. 2022. Front Cardiovasc Med. 8:761591. PubMed
107. Ali S, et al. 2021. PLoS One. 16:e0246646. PubMed
108. Patankar Y, et al. 2015. Am J Physiol Lung Cell Mol Physiol. 309: L902 - L913. PubMed
109. Ioannidis L, et al. 2016. J Immunol. 196: 1227 - 1238. PubMed
110. Wang SS, et al. 2021. Cell Chemical Biology. 28(5):699-710.e5. PubMed
111. Peñaloza HF, et al. 2018. Biochem Biophys Rep. 13:12. PubMed
112. Hsu BE et al. 2019. Cell Rep. 27(13):3902-3915 . PubMed
113. Quenum Zangbede FO, et al. 2018. J Neurosci. 38:6737. PubMed
114. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
115. Qadir AS, et al. 2021. iScience. 24:103348. PubMed
116. Song J, et al. 2021. Am J Physiol Heart Circ Physiol. 320:H323. PubMed
117. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
118. Li YT, et al. 2019. Elife. 8:e47642. PubMed
119. Bitschar K, et al. 2019. Nat Commun. 10:2730. PubMed
120. Wingrove E et al. 2019. Cell reports. 27(4):1277-1292 . PubMed
121. Vasamsetti SB, et al. 2018. Immunity. 49:93. PubMed
122. Ohno-Urabe S, et al. 2018. J Am Heart Assoc. 7:e007389. PubMed
123. Resende M, et al. 2019. J Immunol. 203:2451. PubMed
124. Salvagno C, et al. 2019. Nat Cell Biol. 1.229861111. PubMed
125. Cá B, et al. 2019. Front Microbiol. 1.876388889. PubMed
126. Georgiadou A, et al. 2022. Elife. 11:. PubMed
127. Kwon MY, et al. 2021. J Leukoc Biol. 110:711. PubMed
128. Skokowa J, et al. 2022. Nat Commun. 13:2948. PubMed
129. Lin T, et al. 2021. PLoS Pathog. 17:e1009557. PubMed
130. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
131. Chua Y, et al. 2016. J Immunol. 197: 3771 - 3781. PubMed
132. Ulrich V, et al. 2016. EMBO Mol Med. 8: 643 - 653. PubMed
133. Grayczyk JP et al. 2017. Cell host & microbe. 22(5):678-687 . PubMed
134. Molgora M, et al. 2020. Cell. 182:886. PubMed
135. Chen L, et al. 2021. Theranostics. 11:6668. PubMed
136. Katzmarski N, et al. 2021. Nat Immunol. 22:1382. PubMed
137. Shi J, et al. 2022. Front Pharmacol. 12:818326. PubMed
138. Gautam S, et al. 2020. Am J Physiol Lung Cell Mol Physiol. 319:L661. PubMed
139. Kamei A, et al. 2012. J Infect Dis. 207:39. PubMed
140. Gardner P, et al. 2015. Am J Pathol. 185:1324. PubMed
141. Kuo P, et al. 2016. J Am Heart Assoc. 5: 002610. PubMed
142. Knuplez E, et al. 2021. British Journal of Pharmacology. 178(5):1234-1248. PubMed
143. Matsumoto M, et al. 2021. Cell Host Microbe. 29(6):930-940.e4. PubMed
144. Di Pilato M, et al. 2021. Cell. 184(17):4512-4530.e22. PubMed
145. Zegarra‐Ruiz DF et al. 2018. Cell host & microbe. 25(1):113-127 . PubMed
146. Asahara M, et al. 2022. PLoS One. 17:e0276135. PubMed
147. Zhang XL, et al. 2022. J Am Heart Assoc. 11:e023800. PubMed
148. Andreou T, et al. 2021. J Immunother Cancer. 9:. PubMed
149. Lee GR, et al. 2021. JCI Insight. 6:. PubMed
150. Siolas D, et al. 2021. Cell Reports. 36(8):109578. PubMed
151. Wang M, et al. 2021. iScience. 24(7):102766. PubMed
152. Aryal B, et al. 2016. Nat Commun. 7:12313. PubMed
153. Heuslein J, et al. 2016. Sci Rep. 6: 27029. PubMed
154. Zhao Z, et al. 2019. J Immunol Res. 2019:9561350. PubMed
155. Phadke MS, et al. 2021. Cancer Immunol Res. 9:554. PubMed
156. Weng JH, et al. 2021. Nat Metab. 3:513. PubMed
157. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
158. Cardoso M, et al. 2015. Infect Immun . 83: 3534-3544. PubMed
159. Jaeger N, et al. 2020. Cell Rep. 33:108331. PubMed
160. Zhang J et al. 2019. Cell Rep. 27(9):2679-2689 . PubMed
161. Liu Z, et al. 2020. STAR Protoc. 1:100029. PubMed
162. Oertli M, et al. 2011. J Immunol. 187:3578. PubMed
163. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
164. Wang S, et al. 2022. Blood. 140:171. PubMed
165. Liao YC, et al. 2021. Front Immunol. 12:743030. PubMed
166. Young K, et al. 2021. Cell Stem Cell. . PubMed
167. Cardoso F, et al. 2015. PLoS One. 10: 0131904. PubMed
168. Devi S, et al. 2013. J Exp Med. 210:2321. PubMed
169. Ershaid N, et al. 2019. Nat Commun. 10:4375. PubMed
170. Yáñez A et al. 2017. Immunity. 47(5):890-902 . PubMed
171. Tong Y, et al. 2018. EBioMedicine. 39:132. PubMed

RRID

AB_1877163 (BioLegend Cat. No. 127613)
AB_2227348 (BioLegend Cat. No. 127614)

Antigen Details

Structure

A 21-35 kD GPI-anchorded membrane protein

Distribution

Expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes. The monoclonal antibody RB6-8C5 recognizes both Ly-6G and Ly-6C.

Cell Type

Granulocytes, Macrophages, Monocytes

Biology Area

Immunology, Innate Immunity

Antigen References

Fleming TJ, et al. 1993. J. Immunol. 151:2399.

Gene ID

546644 View all products for this Gene ID

UniProt

View information about Ly-6G on UniProt.org

Documentation

• Technical Data Sheet (pdf)
• Certificate of Analysis
• Safety Data Sheet

Reviews

Related Protocols

• Cell Surface Flow Cytometry Staining Protocol

Related Pages & Pathways

Related FAQs

Other Formats

Concentration & Expiration Lookup

Certificate of Analysis